Mekinist (Novartis Pharmaceuticals Corporation)


Welcome to the PulseAid listing for the Mekinist drug offered from Novartis Pharmaceuticals Corporation. This Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Novartis Pharmaceuticals Corporation
NON-PROPRIETARY NAME: trametinib
SUBSTANCE NAME: TRAMETINIB DIMETHYL SULFOXIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2016-03-17
END MARKETING DATE: 0000-00-00


Mekinist HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMekinist from Novartis Pharmaceuticals Corporation
LABELER NAME: Novartis Pharmaceuticals Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 0.5(mg/1)
START MARKETING DATE: 2016-03-17
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0078-0666_99882454-9825-4ac1-b3fe-a0b09a5cd8de
PRODUCT NDC: 0078-0666
APPLICATION NUMBER: NDA204114

Other TRAMETINIB DIMETHYL SULFOXIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Novartis Pharmaceuticals CorporationMekinist